PRESS RELEASE, September 16, 2019

Auransa to Present New Data on AU-409, a Novel, AI-Generated Drug Candidate for the Treatment of Hepatocellular Carcinoma, at the 13th Annual Conference of the International Liver Cancer Association Oral Presentation to Highlight Promising Preclinical Activity of...

PRESS RELEASE, September 12, 2019

Auransa Announces CEO to Participate on Executive Leadership Panel at the 6th Annual Indy Big Data Conference PALO ALTO, CA – September 12, 2019 – Auransa Inc., an artificial intelligence (AI)-driven biotechnology company developing precision medicines in areas of...

PRESS RELEASE, April 8, 2019

Auransa to Participate in BioCentury’s 26th Annual Future Leaders in the Biotech Industry Conference PALO ALTO, CA – April 8, 2019 – Auransa Inc., an artificial intelligence (AI)-driven biotechnology company developing precision medicines in areas of significant...

SOFTWARE ENGINEER

Auransa is an innovative company that applies cutting edge artificial intelligence (AI), machine learning and advanced analytics to address the most significant challenges in drug discovery and development.Auransa’s SMarTR Engine is a powerful AI-driven computational...

PROJECT MANAGER

Auransa is an AI-driven pharmaceutical company that develops precise medicines for patients in areas of significant unmet medical need. We are redefining precision medicine by applying advanced computation to the discovery and development of drugs and diagnostics for...